Information for Providers

Patients with atrial fibrillation (AFib) are at five times higher risk of stroke

You can change these statistics by—

  1. Educating all of your patients with AFib about anticogulant use
  2. Stopping the use of aspirin as an anticoagulant

Patients with atrial fibrillation are having PREVENTABLE
strokes because they are not taking oral anticoagulants

Myth vs. Reality

Myth: Aspirin prevents stroke and is safe

Reality: Aspirin is neither safe nor effective (Eur Heart J 2015;36:653-6)

Myth: It is risky to resume oral anticoagulation therapy in the months after bleeding

Reality: Benefits generally outweigh risks (Arch Intern Med 2002;162:541-550)

Myth: It is risky to prescribe oral anticoagulants to patients who are at risk of falling

Reality: “… persons taking warfarin must fall about 295 times in 1 year for warfarin to not be the optimal therapy.” (Arch Intern Med 1999;159:677-685)

Myth: Patients who don’t tolerate warfarin won’t tolerate any oral anticoagulant

Reality: Most patients tolerate novel oral anticoagulants (N Engl J Med 2011;364:806-17)

Myth: Patients with paroxysmal AFib have a low risk of stroke

Reality: Risk is about the same for paroxysmal or permanent AF, indicating need for anticoagulation (Circulation 2014;130: e199-e267)

Myth: There is no antidote for novel oral anticoagulants

Reality: An injectable reversal agent (Praxbind®) is available for the novel oral anticoagulant Pradaxa® (dabigatran) (N Engl J Med. 2015;373:511-20)